Skip to main content
Log in

Eberconazole

WAS 2160

  • Section 2: Antifungal Agent
  • Adis R&D Profile
  • Published:
Drugs in R & D Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Font E, del Palacio A, Cuétara S, et al. A phase II dose finding pilot study: topical treatment of tinea corporis and tinea cruris with eberconazole (WAS 2160) cream. Methods Find Exp Clin Pharmacol 1995; 17 Suppl. A: 84

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eberconazole. Drugs R&D 1, 168–169 (1999). https://doi.org/10.2165/00126839-199901020-00012

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00126839-199901020-00012

Keywords

Navigation